REGISTERED
on 02 Aug 2022
Last Applicant/ Owned by
Viale Fulvio Testi, 330
Milano (MI)
IT
I-20126
Serial Number
90585037 filed on 17th Mar 2021
Registration Number
6806282 registered on 02th Aug 2022
Filing Basis
1. intent to use
Disclaimer
NO DATA
DUSKEN
Biochemical and chemical preparations for medical use, namely, chemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseases, cancer, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essentia Read More
Classification Information
Class [005]
Pharmaceutical Products
Biochemical and chemical preparations for medical use, namely, chemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseases, cancer, inflammatory diseases, HIV/AIDS, spinal muscular atrophy, systemic juvenile idiopathic arthritis, polycythaemia vera, essential thrombocythemia, leukemias, myelomas, myelofibrosis, Duchenne muscular dystrophy, Becker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders
Mark Details
Serial Number
No 90585037
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Aug 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 02th Aug 2022 | REGISTERED-PRINCIPAL REGISTER |
| 17th May 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 17th May 2022 | PUBLISHED FOR OPPOSITION |
| 27th Apr 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 14th Apr 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 15th Feb 2022 | ASSIGNED TO EXAMINER |
| 26th Jan 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 26th Jan 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 26th Jan 2022 | ASSIGNED TO LIE |